We offer A RESEARCHER’S PERSPECTIVE, based on a presentation given by Lisa M. Monteggia, Ph.D., of Vanderbilt University, at a zoom event hosted by BBRF. The topic of her presentation was “Studying Ketamine’s Rapid Effects to Unlock Secrets for Developing Better Antidepressants

Our PATHWAYS TO THE FUTURE story is about an unconventional approach to developing new psychiatric drugs. Based on an initiative by the National Institute of Mental Health, it’s called “Fast-Fail” and is designed to weed out the weakest drug candidates early in the process, to

A story about the research of Dr. Kristen Brennand, which 20 years ago might have sounded like science fiction: taking skin or blood cells harmlessly sampled from psychiatric patients, reprogramming them to a stem-cell-like state, and then directing them to redevelop in culture dishes as brain

"A research career is all about a path. And for me, the path really started with BBRF.”

Deanna Barch, Ph.D., a much honored research scientist who now chairs the department of Psychological and Brain Sciences at Washington University in St. Louis, did not take long in life to discover her passion.

“I love the science of it!” says Dr. Hilary Blumberg, a research pioneer who has used advanced imaging to figure out how the brain subtly changes in bipolar disorder, major depression, and other mood disorders. “But what really drives me,” she stresses, “is bringing this work to the point where

At the core of anorexia nervosa is one of our most basic bodily needs, nourishment.

Foundation-supported researchers are featured in Wall Street Journal article

Can we lessen the likelihood of getting psychiatric disorders?

Recent brain scan analysis suggests four distinct kinds of depression, says Conor Liston, M.D., Ph.D., Assistant Professor of Neuroscience and Psychiatry at Weill Cornell Medicine’s Feil Family Brain & Mind